Sitagliptin/Metformin "Glenmark" 50+850 mg filmovertrukne tabletter الدانمرك - الدانماركية - Lægemiddelstyrelsen (Danish Medicines Agency)

sitagliptin/metformin "glenmark" 50+850 mg filmovertrukne tabletter

glenmark arzneimittel gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg

Segluromet الاتحاد الأوروبي - الدانماركية - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.